Status:
UNKNOWN
Short-course Preoperative Chemoradiotherapy for Rectal Cancer
Lead Sponsor:
Jong Hoon Lee
Collaborating Sponsors:
Seoul National University Hospital
Samsung Medical Center
Conditions:
Rectal Cancer
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the early clinical outcome of the short-course preoperative chemoradiotherapy, 33Gy/10 fx and delayed operation after chemoradiation, the investigators initiat...
Eligibility Criteria
Inclusion
- histologically confirmed adenocarcinoma
- distal margin of the tumor located \< 8 cm above the anal verge
- cT3-4 or cN+ classification as determined by endorectal ultrasonography (EUS) and CT
- patient older than age 18 years
- Karnofsky performance score \>= 70
Exclusion
- distant metastasis identified during staging workup
- previous or concurrent malignancy
- pregnant or breast-feeding women
- impending rectal obstruction
- familial adenomatous polyposis
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01431599
Start Date
September 1 2011
End Date
October 1 2017
Last Update
October 10 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center, Korea
Goyang, South Korea
2
Samsung Medical Center
Seoul, South Korea
3
Seoul National University Hospital
Seoul, South Korea